BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36703897)

  • 1. Case report: Two heterozygous pathogenic variants of CYP24A1: A novel cause of hypercalcemia and nephrocalcinosis in adulthood.
    Brunerova L; Remes O; Zoubkova V; Votypka P
    Front Med (Lausanne); 2022; 9():1020096. PubMed ID: 36703897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biallelic and monoallelic pathogenic variants in CYP24A1 and SLC34A1 genes cause idiopathic infantile hypercalcemia.
    Wang Q; Chen JJ; Wei LY; Ding Y; Liu M; Li WJ; Su C; Gong CX
    Orphanet J Rare Dis; 2024 Mar; 19(1):126. PubMed ID: 38504242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations.
    Figueres ML; Linglart A; Bienaime F; Allain-Launay E; Roussey-Kessler G; Ryckewaert A; Kottler ML; Hourmant M
    Am J Kidney Dis; 2015 Jan; 65(1):122-6. PubMed ID: 25446019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: A cross-sectional study.
    Cools M; Goemaere S; Baetens D; Raes A; Desloovere A; Kaufman JM; De Schepper J; Jans I; Vanderschueren D; Billen J; De Baere E; Fiers T; Bouillon R
    Bone; 2015 Dec; 81():89-96. PubMed ID: 26117226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational Spectrum of CYP24A1 Gene in a Cohort of Italian Patients with Idiopathic Infantile Hypercalcemia.
    Gigante M; Santangelo L; Diella S; Caridi G; Argentiero L; D''Alessandro MM; Martino M; Stea ED; Ardissino G; Carbone V; Pepe S; Scrutinio D; Maringhini S; Ghiggeri GM; Grandaliano G; Giordano M; Gesualdo L
    Nephron; 2016; 133(3):193-204. PubMed ID: 27394135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypervitaminosis D Secondary to a
    Collins L; Boehm E; Luxford C; Clifton-Bligh R; Grill V
    JBMR Plus; 2023 Sep; 7(9):e10788. PubMed ID: 37701149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New Mutation of CYP24A1 in a Case of Idiopathic Infantile Hypercalcemia Diagnosed in Adulthood].
    Zanchelli F; Giudicissi A; Neri L; Sgarlato V; Bruno PF; Ruggeri M; Signorotti S; Vetrano D; Buscaroli A
    G Ital Nefrol; 2023 Dec; 40(6):. PubMed ID: 38156538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis.
    Dinour D; Beckerman P; Ganon L; Tordjman K; Eisenstein Z; Holtzman EJ
    J Urol; 2013 Aug; 190(2):552-7. PubMed ID: 23470222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid screening of a recurrent CYP24A1 pathogenic variant opens the way to molecular testing for Idiopathic Infantile Hypercalcemia (IIH).
    De Paolis E; Minucci A; De Bonis M; Scaglione GL; Gervasoni J; Primiano A; Ferraro PM; Cappellani D; Marcocci C; Gambaro G; Capoluongo E
    Clin Chim Acta; 2018 Jul; 482():8-13. PubMed ID: 29574006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP24A1 and SLC34A1 Pathogenic Variants Are Uncommon in a Canadian Cohort of Children with Hypercalcemia or Hypercalciuria.
    Rousseau-Nepton I; Jones G; Schlingmann K; Kaufmann M; Zuijdwijk CS; Khatchadourian K; Gupta IR; Pacaud D; Pinsk MN; Mokashi A; Nour MA; Alexander RT; Rodd CJ
    Horm Res Paediatr; 2021; 94(3-4):124-132. PubMed ID: 34320495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordant Clinical Course of Vitamin-D-Hydroxylase (CYP24A1) Associated Hypercalcemia in Two Adult Brothers With Nephrocalcinosis.
    Jobst-Schwan T; Pannes A; Schlingmann KP; Eckardt KU; Beck BB; Wiesener MS
    Kidney Blood Press Res; 2015; 40(5):443-51. PubMed ID: 26304832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel CYP24A1 Mutation in a Young Male Patient with Nephrolithiasis: Case Report.
    Jiráčková J; Hyšpler R; Alkanderi S; Pavlíková L; Palicka V; Sayer JA
    Kidney Blood Press Res; 2019; 44(4):870-877. PubMed ID: 31288237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic infantile hypercalcemia: mutations in SLC34A1 and CYP24A1 in two siblings and fathers.
    Güven A; Konrad M; Schlingmann KP
    J Pediatr Endocrinol Metab; 2020 Aug; 33(10):1353-1358. PubMed ID: 32866123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP24A1 loss of function: Clinical phenotype of monoallelic and biallelic mutations.
    Carpenter TO
    J Steroid Biochem Mol Biol; 2017 Oct; 173():337-340. PubMed ID: 28093352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do the Heterozygous Carriers of a CYP24A1 Mutation Display a Different Biochemical Phenotype Than Wild Types?
    Brancatella A; Cappellani D; Kaufmann M; Borsari S; Piaggi P; Baldinotti F; Caligo MA; Jones G; Marcocci C; Cetani F
    J Clin Endocrinol Metab; 2021 Mar; 106(3):708-717. PubMed ID: 33249478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases.
    Pronicka E; Ciara E; Halat P; Janiec A; Wójcik M; Rowińska E; Rokicki D; Płudowski P; Wojciechowska E; Wierzbicka A; Książyk JB; Jacoszek A; Konrad M; Schlingmann KP; Litwin M
    J Appl Genet; 2017 Aug; 58(3):349-353. PubMed ID: 28470390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overlapping Phenotypes Associated With
    Molin A; Lemoine S; Kaufmann M; Breton P; Nowoczyn M; Ballandonne C; Coudray N; Mittre H; Richard N; Ryckwaert A; Lavillaureix A; Jones G; Bacchetta J; Kottler ML
    Front Endocrinol (Lausanne); 2021; 12():736240. PubMed ID: 34721296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biochemical phenotypes of adults with monoallelic and biallelic CYP24A1 mutations: evidence of gene dose effect.
    O'Keeffe DT; Tebben PJ; Kumar R; Singh RJ; Wu Y; Wermers RA
    Osteoporos Int; 2016 Oct; 27(10):3121-5. PubMed ID: 27129455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype of Idiopathic Infantile Hypercalcemia Associated with the Heterozygous Pathogenic Variant of
    Bizerea-Moga TO; Chisavu F; Ilies C; Olah O; Marginean O; Gafencu M; Doros G; Stroescu R
    Children (Basel); 2023 Oct; 10(10):. PubMed ID: 37892364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case of Delayed Diagnosis of Idiopathic Infantile Hypercalcemia Due to CYP24A1 Mutation: A 10-Year Journey.
    Khan Z; Mlawa G; Yang YH; Mahamud B
    Cureus; 2023 Aug; 15(8):e42811. PubMed ID: 37664318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.